Jashvant Patel, president of the Federation of Gujarat State Chemists & Druggists (FGSCDA) said, "While the DPCO actually aims at reducing the cost of medicines for patients by increasing the basket of drugs under the pricing control, for a majority of companies the rates would not come down significantly. However, in contrast, the margins of chemists would come under pressure."
Under the old DPCO of 1995, chemists and druggists had a 16 per cent margin for retailers and 8 per cent for wholesalers for drugs whose prices were controlled by the National Pharmaceutical Pricing Authority (NPPA). For non-DPCO drugs the margin was at 20 per cent. However, the new pricing policy mandates further margin reduction of 4 per cent and 2 per cent respectively for retailers and wholesalers on 348 drugs as per the DPCO.
Patel also explained that with inflationary pressures high, the overhead costs have also gone up, and this puts further pressure on margins. The overall turnover of the chemists (around 600,000 wholesale and retail chemists across the country) is around Rs 72,000 crore per annum. Of this around 14,000 chemists in Gujarat account for nearly 10 per cent of the national turnover, Patel claimed.
"Around 50 per cent of our profits would be eroded thanks to the new policy. Nearly 50-60 per cent of the overall turnover now comes from DPCO drugs, and taking a hit in margins would significantly reduce our profitability at a time when cost pressures are high," he explained.
The FGSCDA is affiliated to the All India Organisation of Chemists & Druggist (AIOCD), is now likely to approach the Supreme Court against the DPCO. Patel further informed that the all-India chemists' body is meeting in Goa on July 28, and a decision on the future course of action would be taken then. The AIOCD has already approached the Union government and has submitted a memorandum to the concerned ministries.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app